Paushak Ltd Share Price Rise Over 2 Percent as Company Secures NSE Listing Approval
By Shishta Dutta | Published at: Nov 28, 2025 04:10 PM IST
Mumbai, November 28, 2025: Shares of Paushak Ltd saw a surge during trading session on Friday. The company’s stock price went up by more than 2 percent; the increase was a result of the company’s announcement that its equity shares will be listed and traded on the National Stock Exchange (NSE) starting from December 1, 2025.
Details of NSE Approval and Listing Structure
Paushak Ltd in its letter dated November 27, 2025, informed that the NSE has given the green light for the listing and trading of 2,46,56,912 equity shares of the face value of ₹5 each. It was mentioned that the shares of the company will be traded under the symbol PAUSHAKLTD in the EQ segment from December 1.
It has been clarified that the whole share capital of the company, represented by 1 to 24656912 different numbers, will be the only ones that can be traded in dematerialised form; with a market lot of one share.
Market Performance and Investor Response
The share price at 2:37 pm IST, was ₹622.85 up 2.48%, which means that it was up by ₹15.10. The intraday trading range was from ₹609.00 to ₹621.25, whereas the VWAP was ₹617.51. The stock is still part of the BSE SmallCap index, but the upcoming NSE listing has generated a fresh buzz around the counter. In the last one year, the stock price has been as low as ₹468.25 and as high as ₹991.20, thus pointing to the increased volatility in the specialty chemicals market.
Corporate Communication and Regulatory Confirmation
Paushak informed that the sanction was through NSE Circular Ref. No. 2310/2025 and that trading on the normal market segment would be effective from December 1. The company further added that the listing was a step in line with the company’s objective of offering more liquidity, visibility and accessibility to investors in different markets. Sagar Gandhi, the Company Secretary, made the confirmation in his official communication to the BSE.
Paushak Ltd, a Vadodara-based company, is a leading manufacturer of specialty chemicals and a prominent member of the Alembic Group. The company is focused on phosgene and a wide range of phosgene-based intermediates, which are used in pharmaceuticals, agrochemicals, and performance materials. Besides the inclusion of the NSE listing, Paushak will be dual-listed, both BSE and NSE, from where the market reach will be expanded from December 1, 2025.
REF:https://www.bseindia.com/xml-data/corpfiling/AttachLive/d1eb80cb-201d-43c5-88da-369d269e1c15.pdf
Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations
